Zobrazeno 1 - 10
of 444
pro vyhledávání: '"Kyu-pyo Kim"'
Autor:
Kyu-Pyo Kim, Kang Mo Kim, Baek-Yeol Ryoo, Won-Mook Choi, Won Chul Cha, Mira Kang, Dong Hyun Sinn, Myung Ji Goh, Do Young Kim, Min Ji Lee, Subin Lim, DongKyu Kim, Kyoungdae Baek, Joohyun Kim, Eui Jun Choi, Doik Lee, Jung-Ae Kim, Ki-Hun Kim
Publikováno v:
Liver Cancer, Pp 1-19 (2024)
Introduction: Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality globally, with treatment outcomes closely tied to liver function. This study evaluates the prognostic utility of the albumin-bilirubin (ALBI) score compa
Externí odkaz:
https://doaj.org/article/1aa37e0aefcf496caf8b272eaff7fe77
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Research on the treatment outcomes and mortality of patients with cancer and hip fractures remains limited. We aimed to assess the treatment outcomes and mortality in older patients with cancer and hip fractures. We retrospectively reviewed
Externí odkaz:
https://doaj.org/article/ebf731237a634f3fa27c42c5cf389bb8
Autor:
Ho Yong Kim, Hyun-Ki Min, Hyeong-Woo Song, Ami Yoo, Seonmin Lee, Kyu-Pyo Kim, Jong-Oh Park, You Hee Choi, Eunpyo Choi
Publikováno v:
Drug Delivery, Vol 29, Iss 1, Pp 2897-2911 (2022)
Exosomes are nanosized extracellular vesicles secreted by various cell types, including those of the immune system, such as natural killer (NK) cells. They play a role in intercellular communication by transporting signal molecules between the cells.
Externí odkaz:
https://doaj.org/article/252428bde0614c25ac02551e85074647
Autor:
Sora Kang, Jae Ho Jeong, Shinkyo Yoon, Changhoon Yoo, Kyu-pyo Kim, Hyungwoo Cho, Baek-Yeol Ryoo, Jinhong Jung, Jeong Eun Kim
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Cancer of unknown primary (CUP) is a heterogeneous malignancy in which the primary site of the tumor cannot be identified through standard work-up. The survival outcome of CUP is generally poor, and there is no consensus for treatment. Here,
Externí odkaz:
https://doaj.org/article/8d52adec9532400fb509dd2322c3ccfb
Autor:
Hye‐Young Min, Jaebeom Cho, Jeong Yeon Sim, Hye‐Jin Boo, Ji‐Sun Lee, Seon‐Boon Lee, Young‐Jin Lee, Sung Joo Kim, Kyu‐Pyo Kim, In‐Ja Park, Seung‐Mo Hong, Xue‐Li Zhang, Zhi‐Gang Zhang, Rang‐Woon Park, Ho‐Young Lee
Publikováno v:
Clinical and Translational Medicine, Vol 12, Iss 7, Pp n/a-n/a (2022)
Abstract Background Programmed death‐ligand 1 (PD‐L1) has functional roles in cancer stem‐like cell (CSC) phenotypes and chemoresistance besides immune evasion. Chemotherapy is a common treatment choice for colorectal cancer (CRC) patients; how
Externí odkaz:
https://doaj.org/article/7c30c7044e43480a9579cda7dfd51674
Autor:
Sora Kang, Changhoon Yoo, So Heun Lee, Dongwook Oh, Tae Jun Song, Sang Soo Lee, Jae Ho Jeong, Do Hyun Park, Dong Wan Seo, Jin-hong Park, Dae Wook Hwang, Ki Byung Song, Jae Hoon Lee, Woohyung Lee, Bong Jun Kwak, Sarang Hong, Heung-Moon Chang, Baek-Yeol Ryoo, Kyu-pyo Kim, Song Cheol Kim
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: Adjuvant chemotherapy is the standard treatment after curative-intent surgery for pancreatic ductal adenocarcinoma (PDAC). The phase-3 ESPAC-4 trial demonstrated significantly improved overall survival (OS) with Gemcitabine plus capecitab
Externí odkaz:
https://doaj.org/article/e942281ca3ca4e8a8b4a6d4a9d6b8278
Autor:
Yeong Hak Bang, Jeong Eun Kim, Ji Sung Lee, Sun Young Kim, Kyu-Pyo Kim, Tae Won Kim, Yong Sang Hong
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract There is an unmet medical need for later-line treatment options for patients with metastatic colorectal cancer (mCRC). Considering that, beyond progression, co-treatment with bevacizumab and cytotoxic chemotherapy showed less toxicity and a
Externí odkaz:
https://doaj.org/article/90406605d8d147a48bfed13fe0d89c7a
Autor:
You-Na Sung, Sung Joo Kim, Sun-Young Jun, Changhoon Yoo, Kyu-Pyo Kim, Jae Hoon Lee, Dae Wook Hwang, Shin Hwang, Sang Soo Lee, Seung-Mo Hong
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundGallbladder cancer (GBC) has a poor prognosis. Although complete surgical resection is the only successful approach for improving survival, additional therapeutic modalities are required for recurrent or surgically unresectable GBCs.Materia
Externí odkaz:
https://doaj.org/article/d591750419c2493a8afede64cfd0740b
Autor:
Kyunghye Bang, Jaekyung Cheon, Jae Ho Jeong, Hyeon-Su Im, Kyu-pyo Kim, Baek-Yeol Ryoo, Changhoon Yoo
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Introduction: Liposomal irinotecan (nal-IRI) plus fluorouracil/leucovorin (5-FU/LV) has shown clinical benefit in patients with metastatic pancreatic adenocarcinoma (mPAC) who progressed on gemcitabine-based chemotherapy. However, its role in patient
Externí odkaz:
https://doaj.org/article/7e75156a413148f3ac3d8f82ed564985
Autor:
Young Seob Shin, Hee Hyun Park, Jin-hong Park, Dong-Wan Seo, Sang Soo Lee, Changhoon Yoo, Seonok Kim, Sang Min Yoon, Jinhong Jung, Myung-Hwan Kim, Sung Koo Lee, Do Hyun Park, Tae Jun Song, Dongwook Oh, Baek-Yeol Ryoo, Heung-Moon Chang, Kyu-pyo Kim, Jae Ho Jeong, Jong Hoon Kim
Publikováno v:
Cancers, Vol 14, Iss 5, p 1166 (2022)
In locally advanced pancreatic cancer (LAPC), stereotactic body radiation therapy (SBRT) has been applied as an alternative to concurrent chemoradiotherapy (CCRT); however, direct comparative evidence between these two modalities is scarce. The aim o
Externí odkaz:
https://doaj.org/article/7f82267258c74895b43c70667bf987c0